Lanean...
Eculizumab in the treatment of Shiga toxin haemolytic uraemic syndrome
Haemolytic uraemic syndrome (HUS) remains a leading cause of paediatric acute kidney injury (AKI). Haemolytic uraemic syndrome is characterised by the triad of microangiopathic haemolytic anaemia, thrombocytopenia and AKI. In ~ 90% of cases, HUS is a consequence of infection with Shiga toxin-produci...
Gorde:
| Argitaratua izan da: | Pediatr Nephrol |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Springer Berlin Heidelberg
2018
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6660499/ https://ncbi.nlm.nih.gov/pubmed/30058046 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00467-018-4025-0 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|